GUARDIAN PHRMCY SERVICES-A (GRDN) Fundamental Analysis & Valuation
NYSE:GRDN • US40145W1018
Current stock price
39.49 USD
+0.34 (+0.87%)
At close:
39.49 USD
0 (0%)
After Hours:
This GRDN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GRDN Profitability Analysis
1.1 Basic Checks
- In the past year GRDN was profitable.
- In the past year GRDN had a positive cash flow from operations.
- Of the past 5 years GRDN 4 years were profitable.
- In the past 5 years GRDN always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 11.93%, GRDN belongs to the top of the industry, outperforming 97.00% of the companies in the same industry.
- GRDN's Return On Equity of 23.92% is amongst the best of the industry. GRDN outperforms 93.00% of its industry peers.
- GRDN has a better Return On Invested Capital (19.24%) than 94.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.93% | ||
| ROE | 23.92% | ||
| ROIC | 19.24% |
ROA(3y)-4.52%
ROA(5y)1.44%
ROE(3y)10.51%
ROE(5y)36.52%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- GRDN's Profit Margin of 3.40% is fine compared to the rest of the industry. GRDN outperforms 70.00% of its industry peers.
- GRDN's Profit Margin has improved in the last couple of years.
- GRDN has a better Operating Margin (5.02%) than 61.00% of its industry peers.
- GRDN's Operating Margin has improved in the last couple of years.
- With a Gross Margin value of 20.21%, GRDN perfoms like the industry average, outperforming 46.00% of the companies in the same industry.
- In the last couple of years the Gross Margin of GRDN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.02% | ||
| PM (TTM) | 3.4% | ||
| GM | 20.21% |
OM growth 3Y-4.27%
OM growth 5Y2.31%
PM growth 3Y-4.47%
PM growth 5Y4.63%
GM growth 3Y-0.4%
GM growth 5Y0.23%
2. GRDN Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so GRDN is creating value.
- Compared to 1 year ago, GRDN has about the same amount of shares outstanding.
- The number of shares outstanding for GRDN has been increased compared to 5 years ago.
- Compared to 1 year ago, GRDN has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 11.68 indicates that GRDN is not in any danger for bankruptcy at the moment.
- GRDN's Altman-Z score of 11.68 is amongst the best of the industry. GRDN outperforms 97.00% of its industry peers.
- There is no outstanding debt for GRDN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 11.68 |
ROIC/WACC2.15
WACC8.94%
2.3 Liquidity
- A Current Ratio of 1.38 indicates that GRDN should not have too much problems paying its short term obligations.
- With a Current ratio value of 1.38, GRDN perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
- A Quick Ratio of 1.11 indicates that GRDN should not have too much problems paying its short term obligations.
- GRDN has a Quick ratio of 1.11. This is comparable to the rest of the industry: GRDN outperforms 45.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.38 | ||
| Quick Ratio | 1.11 |
3. GRDN Growth Analysis
3.1 Past
- GRDN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 142.06%, which is quite impressive.
- GRDN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 19.43% yearly.
- Looking at the last year, GRDN shows a quite strong growth in Revenue. The Revenue has grown by 17.93% in the last year.
- Measured over the past years, GRDN shows a quite strong growth in Revenue. The Revenue has been growing by 14.50% on average per year.
EPS 1Y (TTM)142.06%
EPS 3Y10.91%
EPS 5Y19.43%
EPS Q2Q%73.68%
Revenue 1Y (TTM)17.93%
Revenue growth 3Y16.81%
Revenue growth 5Y14.5%
Sales Q2Q%17.44%
3.2 Future
- GRDN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.31% yearly.
- GRDN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.81% yearly.
EPS Next Y57.11%
EPS Next 2Y34.22%
EPS Next 3Y24.31%
EPS Next 5YN/A
Revenue Next Year-1.84%
Revenue Next 2Y2.79%
Revenue Next 3Y4.81%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. GRDN Valuation Analysis
4.1 Price/Earnings Ratio
- GRDN is valuated quite expensively with a Price/Earnings ratio of 51.29.
- Compared to the rest of the industry, the Price/Earnings ratio of GRDN is on the same level as its industry peers.
- When comparing the Price/Earnings ratio of GRDN to the average of the S&P500 Index (27.18), we can say GRDN is valued expensively.
- GRDN is valuated quite expensively with a Price/Forward Earnings ratio of 32.64.
- GRDN's Price/Forward Earnings is on the same level as the industry average.
- GRDN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 37.96, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 51.29 | ||
| Fwd PE | 32.64 |
4.2 Price Multiples
- GRDN's Enterprise Value to EBITDA ratio is in line with the industry average.
- GRDN's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.98 | ||
| EV/EBITDA | 25.39 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- GRDN has a very decent profitability rating, which may justify a higher PE ratio.
- GRDN's earnings are expected to grow with 24.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.9
PEG (5Y)2.64
EPS Next 2Y34.22%
EPS Next 3Y24.31%
5. GRDN Dividend Analysis
5.1 Amount
- No dividends for GRDN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
GRDN Fundamentals: All Metrics, Ratios and Statistics
39.49
+0.34 (+0.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-11 2026-03-11/amc
Earnings (Next)05-11 2026-05-11
Inst Owners57.25%
Inst Owner Change0%
Ins Owners11.39%
Ins Owner Change24.72%
Market Cap2.50B
Revenue(TTM)1.45B
Net Income(TTM)49.22M
Analysts87.27
Price Target40.39 (2.28%)
Short Float %8.89%
Short Ratio5.43
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.96%
Min EPS beat(2)-13.49%
Max EPS beat(2)29.41%
EPS beat(4)1
Avg EPS beat(4)-3.46%
Min EPS beat(4)-18.3%
Max EPS beat(4)29.41%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.33%
Min Revenue beat(2)0.17%
Max Revenue beat(2)4.48%
Revenue beat(4)4
Avg Revenue beat(4)1.88%
Min Revenue beat(4)0.17%
Max Revenue beat(4)4.48%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.14%
PT rev (3m)16.47%
EPS NQ rev (1m)6.98%
EPS NQ rev (3m)21.05%
EPS NY rev (1m)14.59%
EPS NY rev (3m)27.53%
Revenue NQ rev (1m)-2.75%
Revenue NQ rev (3m)-3.42%
Revenue NY rev (1m)-1.64%
Revenue NY rev (3m)-2.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 51.29 | ||
| Fwd PE | 32.64 | ||
| P/S | 1.73 | ||
| P/FCF | 30.98 | ||
| P/OCF | 24.94 | ||
| P/B | 12.15 | ||
| P/tB | 23.25 | ||
| EV/EBITDA | 25.39 |
EPS(TTM)0.77
EY1.95%
EPS(NY)1.21
Fwd EY3.06%
FCF(TTM)1.27
FCFY3.23%
OCF(TTM)1.58
OCFY4.01%
SpS22.88
BVpS3.25
TBVpS1.7
PEG (NY)0.9
PEG (5Y)2.64
Graham Number7.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.93% | ||
| ROE | 23.92% | ||
| ROCE | 28.85% | ||
| ROIC | 19.24% | ||
| ROICexc | 26.02% | ||
| ROICexgc | 55.01% | ||
| OM | 5.02% | ||
| PM (TTM) | 3.4% | ||
| GM | 20.21% | ||
| FCFM | 5.57% |
ROA(3y)-4.52%
ROA(5y)1.44%
ROE(3y)10.51%
ROE(5y)36.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y6.92%
ROICexgc growth 5Y6.02%
ROICexc growth 3Y3.44%
ROICexc growth 5Y8.17%
OM growth 3Y-4.27%
OM growth 5Y2.31%
PM growth 3Y-4.47%
PM growth 5Y4.63%
GM growth 3Y-0.4%
GM growth 5Y0.23%
F-Score8
Asset Turnover3.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 87.51% | ||
| Cap/Sales | 1.35% | ||
| Interest Coverage | 111.85 | ||
| Cash Conversion | 105.49% | ||
| Profit Quality | 163.98% | ||
| Current Ratio | 1.38 | ||
| Quick Ratio | 1.11 | ||
| Altman-Z | 11.68 |
F-Score8
WACC8.94%
ROIC/WACC2.15
Cap/Depr(3y)83.37%
Cap/Depr(5y)81.5%
Cap/Sales(3y)1.36%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)142.06%
EPS 3Y10.91%
EPS 5Y19.43%
EPS Q2Q%73.68%
EPS Next Y57.11%
EPS Next 2Y34.22%
EPS Next 3Y24.31%
EPS Next 5YN/A
Revenue 1Y (TTM)17.93%
Revenue growth 3Y16.81%
Revenue growth 5Y14.5%
Sales Q2Q%17.44%
Revenue Next Year-1.84%
Revenue Next 2Y2.79%
Revenue Next 3Y4.81%
Revenue Next 5YN/A
EBIT growth 1Y215.55%
EBIT growth 3Y11.83%
EBIT growth 5Y17.15%
EBIT Next Year89.59%
EBIT Next 3Y30.79%
EBIT Next 5YN/A
FCF growth 1Y94.05%
FCF growth 3Y36.47%
FCF growth 5Y12.76%
OCF growth 1Y72.97%
OCF growth 3Y27.37%
OCF growth 5Y13.76%
GUARDIAN PHRMCY SERVICES-A / GRDN Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for GUARDIAN PHRMCY SERVICES-A?
ChartMill assigns a fundamental rating of 6 / 10 to GRDN.
What is the valuation status of GUARDIAN PHRMCY SERVICES-A (GRDN) stock?
ChartMill assigns a valuation rating of 4 / 10 to GUARDIAN PHRMCY SERVICES-A (GRDN). This can be considered as Fairly Valued.
What is the profitability of GRDN stock?
GUARDIAN PHRMCY SERVICES-A (GRDN) has a profitability rating of 7 / 10.
Can you provide the financial health for GRDN stock?
The financial health rating of GUARDIAN PHRMCY SERVICES-A (GRDN) is 7 / 10.
What is the earnings growth outlook for GUARDIAN PHRMCY SERVICES-A?
The Earnings per Share (EPS) of GUARDIAN PHRMCY SERVICES-A (GRDN) is expected to grow by 57.11% in the next year.